|
KMID : 1037120220400010066
|
|
The World Journal of Men′s Health
2022 Volume.40 No. 1 p.66 ~ p.73
|
|
|
Beyond Prostate Specific Antigen: New Prostate Cancer Screening Options
|
|
Narain Tushar Aditya
Sooriakumaran Prasanna
|
|
|
Abstract
|
|
|
|
Prostate specific antigen (PSA) is one of the best-known biomarkers for screening, diagnosis and follow-up of patients for prostate cancer. Owing to several inherent limitations with PSA, various newer blood and urinary based biomarkers have been evaluated in pursuit of better detection and risk stratification of prostate cancer cases. A combination of these different markers, in adjunct with clinical risk factors, and recent advances in imaging promises to offer better diagnostic performance with clearer risk stratification guiding therapeutics. We carried out an extensive literature search for the different biomarkers available for screening and diagnosis of prostate cancer, compared their performance with serum PSA to allow clinicians to draw meaningful conclusions to offer their patients a more personalized medical care.
|
|
|
KEYWORD
|
|
|
Biomarkers, Prostate cancer, Prostate specific antigen, Screening
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
   
|